Photo Credit: Medical Images / Dorothea Zucker-Franklin
Flow cytometry is recommended in the NCCN Guidelines and European Organisation for Research and Treatment (EORTC) cutaneous lymphoma task force for objective assessment of malignant T-cell counts in CTCL subtypes Mycosis Fungoides and Sézary Syndrome.1,2 Despite the increased use of flow cytometry, there is a need for standardization of blood testing and comprehensive educational resources.3
Kyowa Kirin, Inc. has engaged several disease-state experts to provide information and resources about blood involvement in CTCL, why it matters, and how flow cytometry is used in testing for blood involvement.